Belmore Neidrauer was recognized for acting on behalf of Janssen in the LMG Life Sciences Patent Impact Case of the Year Teva v Janssen (2023 FCA 68) at the 2023 LMG Life Sciences Americas Awards.
Belmore Neidrauer is pleased to announce that the firm has been shortlisted for Patent Litigation Firm of the Year - Canada at the upcoming LMG Life Sciences Americas Awards. Belmore Neidrauer partner Peter Wilcox has also been shortlisted for Patent Litigator of the Year – Canada.
IAM Patent 1000’s newest edition continues to recognize partners Peter Wilcox, Marian Wolanski and Stephanie Anderson as leading practitioners in intellectual property litigation.
This recognition as one of the Most Frequently Recommended firms for Intellectual Property Litigation is a testament to the depth of talent at the firm and reflects our position as a top firm for IP litigation in Canada.